Transdermal delivery of meloxicam using niosomal hydrogels: in vitro and pharmacodynamic evaluation

References

• Badran MM, Kuntsche J, Fahr A. Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: dependency on needle size and applied formulation. Eur J Pharm Sci 2009;36:511–523
   PubMed Web of Science ®Google Scholar
• Shakeel F, Shafiq S, Haq N, et al. Nanoemulsions as potential vehicles for transdermal and dermal delivery of hydrophobic compounds: an overview. Expert Opin Drug Deliv 2012;9:953–974
   PubMed Web of Science ®Google Scholar
• Shakeel F, Haq N, Al-Dhfyan A, et al. Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil: a preliminary study. Drug Deliv. [Epub ahead of print]. doi: 10.3109/10717544.3013.868557
   Google Scholar
• El-Badry M, Fetih G, Shakeel F. Comparative topical delivery of antifungal drug croconazole using liposome and micro-emulsion-based gel formulations. Drug Deliv 2014;21:34–43
   PubMed Web of Science ®Google Scholar
• Trommer H, Neubert RHH. Overcoming the stratum corneum: the modulation of skin penetration: a review. Skin Pharmacol Physiol 2006;19:106–121
   PubMed Web of Science ®Google Scholar
• Ah YC, Choi JK, Choi YK, et al. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization. Int J Pharm 2010;385:12–19
   PubMed Web of Science ®Google Scholar
• Barry BW. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 2001;14:101–114
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004;56:603–618
   PubMed Web of Science ®Google Scholar
• Manconi M, Valenti D, Sinico C, et al. Niosomes as carriers for tretinoin II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm 2003;260:261–263
   PubMed Web of Science ®Google Scholar
• Handjani-Vila RM, Rlbier A, Rondot B, Vanlerberghe G. Dispersions of lamellar phases of non-ionic lipids in cosmetic products. Int J Cosmetic Sci 1979;1:303–305
   PubMed Web of Science ®Google Scholar
• Shahiwala A, Misra A. Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci 2002;5:220–225
   PubMed Web of Science ®Google Scholar
• Lala S, Pramanick S, Mukhopadhyay S, et al. Harmine: evaluation of its antileishmanial properties in various vesicular delivery systems. J Drug Target 2004;12:165–168
   PubMed Web of Science ®Google Scholar
• Luciani A, Olivier JC, Clement O, et al. Glucose-receptor MR imaging of tumors: study in mice with PEGylated paramagnetic niosomes. Radiology 2004;231:135–142
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Ismail S, Kamal A, Alany RG. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. J Pharm Sci 2011;100:1833–1846
   PubMed Web of Science ®Google Scholar
• Patel KK, Kumar P, Thakkar HP. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS Pharm Sci Tech 2012;13:1502–1510
   PubMed Web of Science ®Google Scholar
• Chang JS, Huang YB, Hou SS, et al. Formulation optimization of meloxicam sodium gel using response surface methodology. Int J Pharm 2007;338:48–54
   PubMed Web of Science ®Google Scholar
• Han HK, Choi HK. Improved absorption of meloxicam via salt formation with ethanolamines. Eur J Pharm Biopharm 2007;65:99–103
   PubMed Web of Science ®Google Scholar
• Ambrus R, Kocbek P, Kristl J, et al. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam. Int J Pharm 2009;381:153–159
   PubMed Web of Science ®Google Scholar
• Seedher N, Bhatia S. Mechanism of interaction of the non-steroidal antiinflammatory drugs meloxicam and nimesulide with serum albumin. J Pharm Biomed Anal 2005;39:257–262
   PubMed Web of Science ®Google Scholar
• Yuan Y, Li SM, Mo FK, Zhong DF. Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm 2006;321:117–123
   PubMed Web of Science ®Google Scholar
• Bae JW, Kim MJ, Jang CG, Lee SY. Determination of meloxicam in human plasma using a HPLC method with UV detection and its application to a pharmacokinetic study. J Chromatogr B 2007;859:69–73
   PubMed Web of Science ®Google Scholar
• Jantharaprapap R, Stagni G. Effects of penetration enhancers on in vitro permeability of meloxicam gels. Int J Pharm 2007;343:26–33
   PubMed Web of Science ®Google Scholar
• Quintana R, Kopcow L, Marconi G, et al. Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model. Fertil Steril 2008;9:1511–1516
   Google Scholar
• El-Menshawe SF, Hussein AK. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery. Pharm Develop Technol 2013;18:779–786
   PubMed Web of Science ®Google Scholar
• El-Megrab NA, El-Nahas HM, Balata GF. Formulation and evaluation of meloxicam gels for topical administration. Saudi Pharm J 2006;14:155–162
   Google Scholar
• Patel M, Joshi A, Hassanjadeh H, et al. Quantification of dermal and transdermal delivery of meloxicam gels in rabbits. Drug Develop Ind Pharm 2011;37:613–617
   PubMed Web of Science ®Google Scholar
• Inal O, Yapar A. Effect of mechanical properties on the release of meloxicam from poloxamer gel bases. Ind J Pharm Sci 2013;75:700–706
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang S, Xu H, et al. Properties of topically applied organogels: rheology and in vitro drug release. Asian J Pharm Sci 2008;3:175–183
   Google Scholar
• Bayindir ZS, Yuksel N. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 2010;99:2049–2060
   PubMed Web of Science ®Google Scholar
• Kamboj S, Saini V, Bala S. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement. World Sci J 2014;2014:E959741
   Web of Science ®Google Scholar
• El-Ridy MS, Abdelbary A, Nasr AA, et al. Niosomal encapsulation of the antitubercular drug, pyrazinamide. Drug Develop Ind Pharm 2011;37:1110–1118
   PubMed Web of Science ®Google Scholar
• Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 2008;361:104–111
   PubMed Web of Science ®Google Scholar
• Garcia MS, Sanchez-Pedreno C, Alberto MI, Marti J. Spectrophotometric methods for determining meloxicam in pharmaceuticals using batch and flow injection procedures. Eur J Pharm Sci 2000;9:311–316
   PubMed Web of Science ®Google Scholar
• EL-Badry M, Fathy M. Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinyl pyrrolidone K-30. Drug Dev Ind Pharm 2006;32:141–150
   PubMed Web of Science ®Google Scholar
• Aggarwal D, Pal D, Mitra AK, Kaur IP. Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor. Int J Pharm 2007;338:21–26
   PubMed Web of Science ®Google Scholar
• Schmalka IR. Artificial-skin I. preparation of pluronic F-127 gels for treatment of burns. J Biomed Matter Res 1972;6:571–582
   PubMedGoogle Scholar
• French DL, Haglund BO, Himmelstein KJ, Mauger JW. Controlled release of substituted benzoic and naphthalic acids using carbopol gels: measurement of drug concentration profiles and correlation to release rate kinetics. Pharm Res 1995;12:1513–1520
   PubMed Web of Science ®Google Scholar
• El-Badry M, Fetih G. Preparation, charactarization and anti-inflammatory activity of celecoxib chitosan gel formulations. J Drug Deliv Sci Technol 2011;21:201–206
   Web of Science ®Google Scholar
• Varshosaz J, Tabbakhian M, Salmani Z. Design of a thermosensitive chitosan/poloxamer in situ gel for ocular delivery of ciprofloxacin. Open Drug Deliv J 2008;2:61–70
   Google Scholar
• Al-Suwayeh SA. Transdermal delivery of isoradipine through excised rabbit skin effect of vehicle and drug concentration. Saudi Pharm J 2003;11:46–52
   Google Scholar
• Wada Y, Etoh Y, Ohira A, et al. Percutaneous absorbtion and anti-inflammatory activity of indomethacin in ointment. J Pharm Pharmcol 1982;34:467–468
   PubMed Web of Science ®Google Scholar
• Escribano E, Calpena AC, Queralt J, et al. Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula. Eur J Pharm Sci 2003;19:203–210
   PubMed Web of Science ®Google Scholar
• Abdelbary G, El-Gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS Pharm Sci Tech 2008;9:740–747
   PubMed Web of Science ®Google Scholar
• Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS Pharm Sci Tech 2010;11:1119–1127
   PubMed Web of Science ®Google Scholar
• El-Samaligy MS, Afifi NN, Mahmoud EA. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm 2006;308:140–148
   PubMed Web of Science ®Google Scholar
• El-Maghraby GM. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effect of cosurfactant. Int J Pharm 2008;355:285–292
   PubMedGoogle Scholar
• Hirano E, Morimoto K, Takeeda T, et al. Pharmaceutical studies of polyacrylic acid aqueous gel bases. II absorption of ibuprofen from gel preparations following rectal administration in rats. Chem Pharm Bull 1980;28:3521–3526
   PubMed Web of Science ®Google Scholar
• Ismail S, Mohamed AA, Abdel-Mohsen MG, Hassan SA. Bioavilability of carbachol chloride from different gel formulations. Bull Pharm Sci Assuit Uni 1990;13:125–133
   Google Scholar
• Macedo T, Block LH, Shukla AJ. Release of tolmetin from carbomer gel systems. Drug Develop Ind Pharm 1993;19:887–902
   Web of Science ®Google Scholar
• Ning M, Guo Y, Pan H, et al. Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug Develop Ind Pharm 2005;31:375–383
   PubMed Web of Science ®Google Scholar
• Hilton J, Woolen BH, Scott RC, et al. Vehicle effects on the in vitro precutaneous absorption through rate and human skin. Pharm Res 1994;11:1396–1400
   PubMed Web of Science ®Google Scholar